Instituts de recherche en santé du Canada
570 556 captures · dernière capture : 3 mai 2026
Page d’accueil :https://cihr-irsc.gc.ca/f/193.html
Le français est une traduction alpha automatisée. Pour le texte officiel, consultez la version anglaise.
Explorateur d’archives
Parcourir et rechercher des captures
Note importante
Parcourez et recherchez des captures historiques. Ceci est une archive — pas des directives actuelles ni un avis médical. Le contenu archivé peut être incomplet, périmé ou remplacé. Pour des recommandations à jour, consultez toujours le site officiel de la source.
Pour plus de contexte sur la couverture et les méthodes de capture, voir Méthodes et couverture.
Parcourir les sites archivés
Santé Canada
386 223 captures · dernière capture : 14 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-canada.html
Agence de la santé publique du Canada
243 880 captures · dernière capture : 28 avr. 2026
Page d’accueil :https://www.canada.ca/fr/sante-publique.html
Fact Sheets Blood safety in Canada: Restriction lifted for men who have sex with men [2022-04-28] Biosimilar biologic drugs in Canada: Fact Sheet [2019-08-27] Plasma donation in Canada [2013-04-11] Questions and Answers: Regulation of Medicinal Maggots / Medicinal Leeches…
Association Bilateral Meeting - BIOTECanada - Meeting Minutes - 2011-11-16 Bilateral meeting between BIOTECanada and Health Canada Wednesday, November 16, 2011 1:30 - 3:30pm 200 Tunney's Pasture Driveway, Ottawa, Ontario Table of Contents Attendees Welcome and introductions…
Activities - Canada.ca
Handbook for health care professionals on biosimilar biologic drugs: Case studies Overview About Data requirements Immunogenicity Authorization of biosimilars Monitoring Access to biosimilars Appendices Case studies On this page Kanjinti, a biosimilar to Herceptin Inflectra…
Handbook for health care professionals on biosimilar biologic drugs: Appendices Overview About Data requirements Immunogenicity Authorization of biosimilars Monitoring Access to biosimilars Appendices Case studies On this page Glossary Definitions Glossary ADA anti-drug…
Handbook for health care professionals on biosimilar biologic drugs: Access to biosimilars and communicating with patients Overview About Data requirements Immunogenicity Authorization of biosimilars Monitoring Access to biosimilars Appendices Case studies On this page Health…
Handbook for health care professionals on biosimilar biologic drugs: Monitoring safety and effectiveness Overview About Data requirements Immunogenicity Authorization of biosimilars Monitoring Access to biosimilars Appendices Case studies On this page The risk management plan…
Handbook for health care professionals on biosimilar biologic drugs: Authorization of biosimilars Overview About Data requirements Immunogenicity Authorization of biosimilars Monitoring Access to biosimilars Appendices Case studies On this page Regulatory authorization How Canada…
Handbook for health care professionals on biosimilar biologic drugs: Immunogenicity Overview About Data requirements Immunogenicity Authorization of biosimilars Monitoring Access to biosimilars Appendices Case studies Addressing a key safety issue: immunogenicity Biologic drugs…
Handbook for health care professionals on biosimilar biologic drugs: Data requirements, labelling and indications Overview About Data requirements Immunogenicity Authorization of biosimilars Monitoring Access to biosimilars Appendices Case studies On this page Data requirements…
Page 4197 sur 6399Affichage de 41961 à 41970 sur 63986
Version préliminaire : la couverture est limitée au corpus actuel et les fonctionnalités peuvent changer.
